Type V osteogenesis imperfecta: a new form of brittle bone disease.

PubWeight™: 2.74‹?› | Rank: Top 1%

🔗 View Article (PMID 10976985)

Published in J Bone Miner Res on September 01, 2000

Authors

F H Glorieux1, F Rauch, H Plotkin, L Ward, R Travers, P Roughley, L Lalic, D F Glorieux, F Fassier, N J Bishop

Author Affiliations

1: Genetics Unit, Shriners Hospital, Montréal, Québec, Canada.

Articles citing this

Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet (2010) 2.39

Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A (2014) 1.70

A single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Hum Genet (2012) 1.70

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest (2002) 1.59

A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus. Am J Hum Genet (2012) 1.57

EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta. Eur J Hum Genet (2011) 1.50

Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation. J Bone Miner Res (2013) 1.44

Osteogenesis Imperfecta: A Review with Clinical Examples. Mol Syndromol (2011) 1.38

New genes in bone development: what's new in osteogenesis imperfecta. J Clin Endocrinol Metab (2013) 1.29

Unexplained fractures in infancy: looking for fragile bones. Arch Dis Child (2007) 1.22

Syndromes with congenital brittle bones. BMC Pediatr (2004) 1.12

Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation. Curr Opin Pediatr (2014) 1.12

Genetic evaluation of suspected osteogenesis imperfecta (OI). Genet Med (2006) 1.04

Modeling the benefits of pamidronate in children with osteogenesis imperfecta. J Clin Invest (2002) 1.01

Clinical and radiological manifestations of osteogenesis imperfecta type V. J Korean Med Sci (2006) 1.00

CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII. Bone (2009) 0.99

Novel quantitative trait loci for central corneal thickness identified by candidate gene analysis of osteogenesis imperfecta genes. Hum Genet (2009) 0.97

Potential implications of cell therapy for osteogenesis imperfecta. Int J Clin Rheumtol (2009) 0.95

Hyperplastic callus formation in osteogenesis imperfecta type V: follow-up of three generations over ten years. Skeletal Radiol (2008) 0.93

Fassier-Duval femoral rodding in children with osteogenesis imperfecta receiving bisphosphonates: functional outcomes at one year. J Child Orthop (2011) 0.92

Osteopotentia regulates osteoblast maturation, bone formation, and skeletal integrity in mice. J Cell Biol (2010) 0.90

Neutral sphingomyelinase 2 deficiency increases hyaluronan synthesis by up-regulation of Hyaluronan synthase 2 through decreased ceramide production and activation of Akt. J Biol Chem (2012) 0.89

A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor. J Bone Miner Res (2014) 0.88

Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta. Arch Osteoporos (2011) 0.87

Bisphosphonates: effects on osteoblast. Eur J Clin Pharmacol (2012) 0.87

Dentinogenesis imperfecta associated with osteogenesis imperfecta. Dent Res J (Isfahan) (2012) 0.85

Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM5 gene. J Bone Miner Res (2013) 0.84

Quality of life in children with osteogenesis imperfecta treated with oral bisphosphonates (Olpadronate): a 2-year randomized placebo-controlled trial. Eur J Pediatr (2007) 0.84

The radiographic approach to child abuse. Clin Orthop Relat Res (2011) 0.84

Cross-sectional and longitudinal growth patterns in osteogenesis imperfecta: implications for clinical care. Pediatr Res (2015) 0.82

Animal models of osteogenesis imperfecta and related syndromes. J Bone Miner Metab (2007) 0.82

Hyperplastic callus formation in osteogenesis imperfecta type V mimicking osteosarcoma: 4-year follow-up with resolution. Skeletal Radiol (2005) 0.82

Phenotype and genotype analysis of Chinese patients with osteogenesis imperfecta type V. PLoS One (2013) 0.81

Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression. J Clin Endocrinol Metab (2014) 0.81

Case report: osteogenesis imperfecta Elusive cause of fractures. Can Fam Physician (2005) 0.81

Swellings over the Limbs as the Earliest Feature in a Patient with Osteogenesis Imperfecta Type V. Case Rep Orthop (2014) 0.81

Regulation of the bone-restricted IFITM-like (Bril) gene transcription by Sp and Gli family members and CpG methylation. J Biol Chem (2013) 0.81

A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation. J Bone Miner Res (2015) 0.79

A brilliant breakthrough in OI type V. Osteoporos Int (2013) 0.79

Next-generation sequencing of common osteogenesis imperfecta-related genes in clinical practice. Sci Rep (2016) 0.79

Phenotypic characterization of skeletal abnormalities of Osteopotentia mutant mice by micro-CT: a descriptive approach with emphasis on reconstruction techniques. Skeletal Radiol (2011) 0.79

The IFITM5 mutation c.-14C > T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type V. BMC Musculoskelet Disord (2014) 0.79

IFITM5 mutations and osteogenesis imperfecta. J Bone Miner Metab (2015) 0.79

Impaired pyridinoline cross-link formation in patients with osteogenesis imperfecta. J Bone Miner Metab (2008) 0.78

Osteogenesis imperfecta Type VI with severe bony deformities caused by novel compound heterozygous mutations in SERPINF1. J Korean Med Sci (2013) 0.78

Spondylolisthesis caused by extreme pedicle elongation in osteogenesis imperfecta. Eur Spine J (2007) 0.77

Effects of targeted modulation of miR-762 on expression of the IFITM5 gene in Saos-2 cells. Intractable Rare Dis Res (2014) 0.76

Clinical aspects, imaging features, and considerations on bisphosphonate-related osteonecrosis risk in a pediatric patient with osteogenesis imperfecta. Case Rep Dent (2014) 0.75

Osteogenesis imperfecta: a case report and review of literature. Ann Med Health Sci Res (2014) 0.75

Osteogenesis imperfecta type V, spot diagnosis. Pol J Radiol (2010) 0.75

Molecular spectrum and differential diagnosis in patients referred with sporadic or autosomal recessive osteogenesis imperfecta. Mol Genet Genomic Med (2016) 0.75

Clinical utility gene card for: osteogenesis imperfecta. Eur J Hum Genet (2012) 0.75

Identification of a novel COL1A1 frameshift mutation, c.700delG, in a Chinese osteogenesis imperfecta family. Genet Mol Biol (2014) 0.75

A boy with blue sclera and recurrent fractures. Malays Fam Physician (2015) 0.75

Fracture of mandible during yawning in a patient with osteogenesis imperfecta. BMJ Case Rep (2014) 0.75

Childhood Osteoporosis and Presentation of Two Cases with Osteogenesis Imperfecta Type V. Zdr Varst (2015) 0.75

Child abuse and osteogenesis imperfecta: how can they be still misdiagnosed? A case report. Clin Cases Miner Bone Metab (2012) 0.75

Surgical treatment in Osteogenesis Imperfecta - 10 years experience. J Med Life (2013) 0.75

An unusual case of atrophic mandible fracture in a patient with osteogenesis imperfecta and on oral bisphosphonate therapy: Case report. Saudi Dent J (2014) 0.75

Clinical and Molecular Characterization of Osteogenesis Imperfecta Type V. Mol Syndromol (2015) 0.75

Conservative versus surgical treatment of osteogenesis imperfecta: a retrospective analysis of 29 patients. Clin Cases Miner Bone Metab (2012) 0.75

Non-traumatic hypertrophic callus of the fibula mimicking osteosarcoma in osteogenesis imperfecta type V: a case report. Skeletal Radiol (2014) 0.75

Founders lecture 2007: Metabolic bone disease: what has changed in 30 years? Skeletal Radiol (2009) 0.75

Hyperuricemia cosegregating with osteogenesis imperfecta is associated with a mutation in GPATCH8. Hum Genet (2011) 0.75

Osteogenesis imperfecta: pathophysiology and treatment. Wien Med Wochenschr (2015) 0.75

Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing. Osteoporos Int (2017) 0.75

Hypermineralization and high osteocyte lacunar density in osteogenesis imperfecta type V bone indicate exuberant primary bone formation. J Bone Miner Res (2017) 0.75

PHENOTYPIC VARIABILITY IN INDIVIDUALS WITH TYPE V OSTEOGENESIS IMPERFECTA WITH IDENTICAL IFITM5 MUTATIONS. J Rare Disord (2013) 0.75

Confirmation of the pathogenicity of a mutation p.G337C in the COL1A2 gene associated with osteogenesis imperfecta. Medicine (Baltimore) (2017) 0.75

Articles by these authors

Salmonella enteritidis phage type 4 infection: association with hen's eggs. Lancet (1988) 4.31

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med (1998) 3.66

Breastfeeding and catch-up growth in infants born small for gestational age. Acta Paediatr (1997) 2.23

Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology (2000) 2.08

British Paediatric and Adolescent Bone Group's position statement on vitamin D deficiency. BMJ (2012) 2.05

Impact of an early weighing policy on neonatal hypernatraemic dehydration and breast feeding. Arch Dis Child (2007) 2.05

Parapoxvirus infection in red squirrels. Vet Rec (1996) 1.84

Randomized outcome trial of human milk fortification and developmental outcome in preterm infants. Am J Clin Nutr (1996) 1.79

Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone (2002) 1.77

Normative data for iliac bone histomorphometry in growing children. Bone (2000) 1.74

Perinatal metabolism of vitamin D. Am J Clin Nutr (2000) 1.67

Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J Clin Endocrinol Metab (2000) 1.65

Management of fibular hemimelia: amputation or limb lengthening. J Bone Joint Surg Br (1997) 1.63

Randomised trial of nutrition for preterm infants after discharge. Arch Dis Child (1992) 1.62

Prevalence and numbers of Salmonella and Campylobacter spp. on raw, whole chickens in relation to sampling methods. Int J Food Microbiol (2002) 1.60

Epidemiology of soft tissue rheumatism: the influence of the law. J Rheumatol (1991) 1.53

Two outbreaks of Salmonella enteritidis phage type 4 infection associated with the consumption of fresh shell-egg products. Epidemiol Infect (1989) 1.52

Buprenorphine abuse among opiate addicts. Br J Addict (1988) 1.48

Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage: a requisite for tissue engineering of intervertebral disc. Eur Cell Mater (2004) 1.47

Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone (2000) 1.46

Complications of limb-lengthening in children who have an underlying bone disorder. J Bone Joint Surg Am (1998) 1.46

Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Res (1996) 1.43

The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc Natl Acad Sci U S A (1998) 1.43

A national outbreak of Salmonella typhimurium DT 124 caused by contaminated salami sticks. Epidemiol Infect (1989) 1.43

Bone growth and mineralisation in children aged 4 to 10 years. Bone Miner (1991) 1.41

Nonsteroidal antiinflammatory drug desensitization using flurbiprofen (Ansaid) Ann Allergy (1993) 1.40

Polyostotic hyperostosis associated with oviductal tumor in a cockatiel. J Am Vet Med Assoc (1990) 1.39

Repetition strain injury: a 10-year follow-up. Med J Aust (1995) 1.38

Seizure in a scuba diver. Chest (2001) 1.37

Cytokines and inflammation in cartilage degradation. Rheum Dis Clin North Am (1993) 1.33

Trends in incidence of childhood cancer in Australia, 1983-2006. Br J Cancer (2010) 1.29

Bone mass in children: normative values for the 2-20-year-old population. Bone (1995) 1.28

Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Clin Endocrinol Metab (2010) 1.22

The development of bone strength at the proximal radius during childhood and adolescence. J Clin Endocrinol Metab (2001) 1.22

Osteogenesis imperfecta--clinical and molecular diversity. Eur Cell Mater (2003) 1.20

Clonal relationship of Salmonella enterica serovar typhimurium phage type DT104 in Germany and Austria. Zentralbl Bakteriol (1999) 1.19

The mineralization density of iliac crest bone from children with osteogenesis imperfecta. Calcif Tissue Int (1999) 1.19

Bone mineralization and turnover in children with congenital neutropenia, and its relationship to treatment with recombinant human granulocyte-colony stimulating factor. Br J Haematol (1997) 1.18

Bone health in Duchenne muscular dystrophy: a workshop report from the meeting in Cincinnati, Ohio, July 8, 2004. Neuromuscul Disord (2005) 1.17

Microbiological study of ready-to-eat salad vegetables from retail establishments uncovers a national outbreak of salmonellosis. J Food Prot (2003) 1.17

The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults. Int J Obes Relat Metab Disord (2004) 1.16

Influence of puberty on muscle development at the forearm. Am J Physiol Endocrinol Metab (2002) 1.16

Structural changes during development in bovine fetal epiphyseal cartilage. Coll Relat Res (1981) 1.15

Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone. Bone (1998) 1.14

Gender-related differences in the relationship between densitometric values of whole-body bone mineral content and lean body mass in humans between 2 and 87 years of age. Bone (1998) 1.14

Salmonella perils of pet reptiles. Commun Dis Public Health (2000) 1.13

Association of the melioidosis agent Burkholderia pseudomallei with water parameters in rural water supplies in Northern Australia. Appl Environ Microbiol (2010) 1.13

Structural and cellular changes during bone growth in healthy children. Bone (2000) 1.11

Changing the nomenclature of Salmonella. Commun Dis Public Health (1999) 1.11

Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res (Hoboken) (2010) 1.10

A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets. J Clin Endocrinol Metab (1992) 1.09

Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia. J Bone Miner Res (2002) 1.08

A scientific note on the detection of honeybee viruses using real-time PCR (TaqMan) in Varroa mites collected from a Thai honeybee (Apis mellifera) apiary. J Invertebr Pathol (2005) 1.08

Comparative studies of the pathogenesis, antibody immune responses, and homologous protection to porcine and human rotaviruses in gnotobiotic piglets. Adv Exp Med Biol (1997) 1.08

Sex-specific developmental changes in muscle size and bone geometry at the femoral shaft. Bone (2008) 1.07

Gender-specific pubertal changes in volumetric cortical bone mineral density at the proximal radius. Bone (2002) 1.07

Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture. Tissue Eng (1999) 1.07

Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J Anat (1999) 1.07

Bone densities and bone size at the distal radius in healthy children and adolescents: a study using peripheral quantitative computed tomography. Bone (2001) 1.07

Responses of newly hatched chicks to inanition. Vet Rec (1992) 1.06

An outbreak due to peanuts in their shell caused by Salmonella enterica serotypes Stanley and Newport--sharing molecular information to solve international outbreaks. Epidemiol Infect (2004) 1.05

Molecular epidemiology of an outbreak caused by Salmonella enterica serovar Newport in Finland and the United Kingdom. Epidemiol Infect (2000) 1.05

Thirty-three novel COL1A1 and COL1A2 mutations in patients with osteogenesis imperfecta types I-IV. Hum Mutat (2001) 1.02

Bisphosphonate therapy for children and adolescents with secondary osteoporosis. Cochrane Database Syst Rev (2007) 1.01

Vibration treatment in cerebral palsy: A randomized controlled pilot study. J Musculoskelet Neuronal Interact (2010) 1.01

Temporal and spatial expression of bone morphogenetic protein-2, -4, and -7 during distraction osteogenesis in rabbits. Bone (2000) 1.00

Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome. Osteoporos Int (2011) 1.00

Bisphosphonate treatment of bone disease. Arch Dis Child (2005) 1.00

Natural and experimental infection of turkeys with avian paramyxovirus-7. Avian Dis (1997) 1.00

Anabolic and catabolic markers of proteoglycan metabolism in osteoarthritis. Acta Orthop Scand Suppl (1995) 1.00

Contribution of clinical risk factors to bone density-based absolute fracture risk assessment in postmenopausal women. Osteoporos Int (2003) 0.99

Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry. Osteoporos Int (2008) 0.99

CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII. Bone (2009) 0.99

The bone formation defect in idiopathic juvenile osteoporosis is surface-specific. Bone (2002) 0.99

Bone mineralization and turnover in preterm infants at 8-12 years of age: the effect of early diet. J Bone Miner Res (1999) 0.98

Are preterm infants at risk for subsequent fractures? Arch Dis Child (1989) 0.98

Deficient bone formation in idiopathic juvenile osteoporosis: a histomorphometric study of cancellous iliac bone. J Bone Miner Res (2000) 0.96

Effect of dietary phosphate deprivation and supplementation of recipient mice on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice. J Bone Miner Res (1992) 0.96

Normative data on mineralization density distribution in iliac bone biopsies of children, adolescents and young adults. Bone (2009) 0.96

Resection-line involvement in gastric cancer: a continuing problem. Br J Surg (1993) 0.96

Reliability of the gross motor function measure for children with osteogenesis imperfecta. Pediatr Phys Ther (2001) 0.95

Q fever in pregnancy. J Infect (1997) 0.95

A vision on the future of articular cartilage repair. Eur Cell Mater (2014) 0.95

Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna. Bone (2004) 0.94

Donor human milk largely replaces formula-feeding of preterm infants in two urban hospitals. J Perinatol (2012) 0.94

The cortical neuritic pathology of Huntington's disease. Neuropathol Appl Neurobiol (1995) 0.93

Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors. Bone (2004) 0.91

Hospital at home for chronic obstructive pulmonary disease: an integrated hospital and community based generic intermediate care service for prevention and early discharge. Chron Respir Dis (2006) 0.91

Neurofibrillary tangles in progressive supranuclear palsy brains exhibit immunoreactivity to frameshift mutant ubiquitin-B protein. Neurosci Lett (2000) 0.91